zoonot
influenza
virus
circul
poultri
swine
pose
ever
present
threat
human
health
particular
rapid
geograph
expans
highli
pathogen
avian
influenza
hpai
throughout
asia
europ
middl
east
africa
galvan
global
commun
attempt
control
rapidli
grow
threat
despit
success
control
effort
countri
viru
remain
endem
poultri
least
six
countri
continu
caus
human
ill
death
well
countless
outbreak
bird
past
decad
case
death
detect
report
world
health
organ
year
sinc
human
infect
hpai
first
identifi
hong
kong
special
administr
region
peopl
republ
china
virus
evolv
substanti
mutat
reassort
result
multipl
diverg
genotyp
clade
ongo
circul
appropri
result
focu
sequenc
viral
genom
understand
evolut
virus
signific
observ
genet
chang
expand
laboratori
capac
highthroughput
sanger
sequenc
recent
technolog
advanc
nextgener
sequenc
parallel
comput
revolution
quantiti
qualiti
avail
gene
sequenc
abil
quickli
accur
analyz
data
consequ
number
anim
human
influenza
viru
sequenc
avail
public
access
databas
dramat
increas
year
bioinformat
tool
requir
effici
investig
advanc
laboratori
analyt
method
provid
strong
incent
util
molecular
data
pandem
risk
assess
zoonot
influenza
virus
animalhuman
interfac
howev
examin
influenza
sequenc
data
alon
allow
us
assess
pandem
potenti
viru
pandem
risk
assess
util
sequenc
data
take
place
critic
genet
signatur
identifi
laboratori
research
consequ
relev
biolog
properti
phenotyp
critic
genet
featur
includ
base
previou
experiment
valid
predict
confer
virul
andor
abil
transmit
effici
mammal
context
genom
sequenc
mutat
detect
rel
earlier
virus
prototyp
strain
signific
apprais
base
prior
knowledg
genet
marker
phenotyp
test
use
varieti
vitro
vivo
experi
virus
possess
phenotyp
interest
concern
often
becom
candid
reversegenet
studi
essenti
elucid
precis
molecular
correl
given
phenotyp
fig
molecular
epidemiolog
perspect
process
heart
public
health
commun
make
inform
decis
threat
pose
zoonot
influenza
virus
intervent
might
effect
laboratori
worldwid
employ
revers
genet
studi
mechan
hpai
zoonot
influenza
virus
evolv
mechan
influenc
host
receptor
specif
antigen
variat
replic
pathogenesi
drug
suscept
transmiss
besid
use
creat
vaccin
virus
develop
live
attenu
inactiv
prepandem
influenza
vaccin
reversegenet
methodolog
also
use
mani
year
studi
phenotyp
consequ
particular
mutat
includ
genet
chang
confer
gain
function
gof
influenza
viru
gof
studi
focus
sever
research
area
vitro
andor
vivo
replic
mammalian
cell
cultur
anim
host
adapt
mutat
confer
chang
host
suscept
alter
receptor
bind
profil
andor
tropism
mammalian
airway
tissu
enhanc
polymeras
activ
chang
host
antivir
respons
eg
cell
signal
pathway
suscept
antivir
drug
pathogenesi
andor
transmiss
mammalian
anim
model
gof
experi
elucid
key
biolog
principl
provid
scientif
basi
genom
sequencebas
risk
assess
zoonot
virus
pandem
potenti
exampl
molecular
basi
avian
versu
mammalian
influenza
viru
receptor
bind
versu
sialyl
glycan
elucid
larg
gof
experi
recent
studi
identifi
specif
ha
mutat
confer
switch
avian
mammalian
host
receptor
specif
also
demonstr
impact
mutat
abil
viru
effici
infect
human
upper
respiratori
tract
mutat
confer
enhanc
virul
mammalian
model
inhibit
host
antivir
respons
potenti
caus
seriou
human
ill
describ
studi
still
gof
work
character
mutat
confer
resist
neuraminidas
na
inhibitor
data
critic
make
effect
drug
treatment
decis
inform
stockpil
antivir
medic
final
mani
public
describ
mutat
confer
adapt
virus
mammalian
host
transmiss
guinea
pig
ferret
note
mani
case
research
demonstr
loss
function
also
valuabl
risk
assess
type
studi
provid
vital
data
monitor
circul
virus
featur
may
suggest
increas
capabl
humantohuman
transmiss
longterm
adapt
virus
human
mammalian
host
pig
reversegenet
experi
use
wellestablish
ferret
model
measur
respiratori
dropletmedi
transmiss
recent
unabl
identifi
specif
mutat
involv
process
laboratoryderiv
virus
like
wildtyp
counterpart
demonstr
lack
limit
capac
aerosol
transmiss
howev
studi
herfst
et
al
imai
et
al
abl
demonstr
genet
modifi
virus
could
transmit
rel
effici
via
respiratori
droplet
mammalian
host
follow
acquisit
specif
mutat
hemagglutinin
ha
andor
combin
presenc
lysin
posit
protein
sequenc
controversi
spark
studi
continu
reverber
argu
benefit
associ
gof
transmiss
studi
outweigh
risk
other
state
public
health
deriv
littl
benefit
justifi
research
gof
research
resum
follow
end
voluntari
global
moratorium
howev
new
moratorium
fund
certain
type
gof
research
influenza
sever
acut
respiratori
syndrom
sar
middl
east
respiratori
syndrom
mer
virus
place
unit
state
paus
provid
opportun
time
describ
molecular
marker
identifi
controversi
ferret
transmiss
studi
mani
gof
studi
provid
import
inform
public
health
risk
assess
natur
occur
virus
detect
anim
human
outlin
util
molecularli
base
surveil
approach
focus
knowledg
insight
gain
gof
research
inform
influenza
pandem
risk
assess
well
risk
manag
pandem
prepared
present
dramat
increas
number
human
case
caus
hpai
cambodia
outbreak
influenza
china
exampl
result
gof
studi
support
rapid
accur
risk
assess
respons
situat
instanc
molecularli
base
surveil
identifi
natur
occur
mutat
avian
influenza
virus
isol
human
demonstr
gof
studi
increas
transmiss
ferret
model
prompt
public
health
action
describ
keep
larg
bodi
data
gof
public
center
diseas
control
prevent
cdc
collabor
domest
intern
research
compil
publish
amino
acid
mutat
protein
motif
test
experiment
shown
alter
relev
function
aspect
viru
phenotyp
genet
chang
inventori
type
data
use
cdc
mani
year
conduct
molecularli
base
surveil
natur
occur
influenza
virus
end
result
genet
chang
inventori
provid
singl
point
refer
facilit
effici
identif
specif
mutat
motif
viral
protein
might
signal
adapt
mammalian
speci
chang
suscept
antivir
medic
chang
viral
pathogenesi
transmiss
focus
mutat
specif
identifi
confer
gof
phenotyp
veterinari
public
health
expert
use
genet
chang
inventori
help
assess
relev
molecular
marker
identifi
natur
occur
virus
pandem
risk
assess
viral
sequenc
data
weigh
respect
virolog
epidemiolog
trait
newli
identifi
viru
result
year
gof
studi
compil
assist
research
institut
worldwid
risk
assess
natur
occur
influenza
virus
facilit
earli
respons
face
emerg
zoonot
influenza
viru
threat
individu
institut
task
risk
assess
pandem
plan
must
weigh
signific
mutat
detect
via
molecular
surveil
exampl
mutat
associ
human
fatal
eg
may
carri
weight
found
enhanc
virul
mous
model
eg
presenc
pdz
bind
domain
motif
similarli
mutat
previous
found
alter
receptorbind
prefer
virus
avian
human
prefer
would
particular
concern
greater
concern
would
identif
mutat
associ
enhanc
mammalian
transmiss
includ
specif
amino
acid
residu
combin
identifi
herfst
et
al
imai
et
al
confer
respiratori
droplet
transmiss
ferret
recent
instanc
enhanc
surveil
respons
cdc
region
partner
occur
follow
abrupt
rise
human
case
occur
cambodia
time
increas
case
number
detect
public
sequenc
databas
mine
research
identifi
virus
sever
human
infect
possess
mutat
shown
gof
studi
alter
receptorbind
specif
toward
prefer
enhanc
respiratori
droplet
transmiss
clade
viru
ferret
addit
amino
acid
sequenc
comparison
virus
previous
circul
cambodian
clade
virus
reveal
three
ha
substitut
conserv
virus
three
mutat
also
shown
gof
experi
increas
bind
virus
mammalian
host
cell
sialic
acid
receptor
linkag
either
alon
combin
mutat
sequenc
find
directli
led
cdc
dispatch
team
three
subject
matter
expert
cambodia
conduct
epidemiolog
investig
sourc
exposur
poultri
human
case
case
contact
traceback
includ
serolog
analysi
antibodi
retrospect
investig
poultri
death
outbreak
locat
case
discov
addit
intens
effort
undertaken
consolid
analyz
human
anim
epidemiolog
sequenc
data
collabor
across
public
health
veterinari
sector
well
local
region
global
agenc
although
comparison
viral
genom
poultri
environment
sampl
human
sampl
demonstr
mutat
absent
poultri
virus
ii
like
arisen
human
infect
iii
transmit
person
person
enhanc
surveil
improv
laboratori
capac
financi
resourc
result
investig
highlight
util
gof
data
pandem
prepared
find
gof
mutat
like
occur
replic
human
possibl
might
aris
candid
vaccin
viru
cvv
develop
viru
possess
two
marker
describ
imai
et
al
enhanc
ferret
aerosol
transmiss
three
mutat
shown
alter
avian
receptorbind
specif
vaccin
stockpil
manufactur
use
particular
cvv
vaccin
viru
avail
develop
human
use
exclud
select
agent
regul
reduc
time
requir
vaccin
develop
test
least
month
thu
enhanc
global
pandem
prepared
reduct
time
requir
vaccin
develop
basi
creation
librari
cvv
emerg
influenza
pandem
threat
approach
taken
global
influenza
surveil
respons
system
mani
year
due
continu
evolut
antigen
drift
detect
mani
subtyp
avian
swine
influenza
virus
priorit
cvv
develop
requir
meet
need
priorit
research
decis
influenza
risk
assess
tool
irat
develop
influenza
divis
cdc
togeth
global
consortium
anim
public
health
expert
offer
standard
set
consider
appli
evalu
virus
pandem
potenti
tool
use
addit
model
base
multiattribut
decis
analysi
integr
weight
element
laboratori
field
observ
collect
assess
molecular
characterist
circul
viru
togeth
factor
incid
human
infect
popul
immun
geograph
host
distribut
antigen
variat
andor
extent
overal
genet
diversif
provid
object
approach
measur
potenti
risk
given
strain
subtyp
group
virus
recent
emerg
lowpathogen
avian
influenza
lpai
viru
caus
human
infect
china
like
emerg
pandem
influenza
viru
instruct
molecular
surveil
perspect
ha
neuraminidas
na
gene
close
relat
previous
recogn
influenza
virus
despit
lack
high
sequenc
ident
viru
known
virus
mani
structur
function
motif
lpai
hpai
virus
remain
conserv
particularli
amino
acid
domain
make
three
major
structur
element
receptor
bind
site
rb
addit
na
enzymat
activ
site
target
na
inhibitor
share
homolog
na
protein
influenza
subtyp
virus
final
intern
gene
describ
virus
share
common
ancestri
lineag
virus
ancestri
retain
intern
gene
mani
genotyp
thu
mani
gof
mutat
describ
surfac
intern
protein
sequenc
virus
assess
context
viru
sequenc
deposit
databas
earli
wave
human
infect
china
within
hour
post
sequenc
data
cdc
investig
use
genet
chang
inventori
identifi
sever
mutat
describ
previous
virus
shown
possess
gof
phenotyp
increas
respiratori
droplet
transmiss
ferret
use
number
ha
ha
mammalian
host
adapt
enhanc
virul
mice
earli
detect
molecular
marker
virus
isol
human
gave
public
health
author
evid
virus
pose
immedi
pandem
threat
base
sequenc
data
alon
develop
candid
vaccin
viru
began
within
day
use
synthet
biolog
virus
obtain
human
case
china
subsequ
share
intern
partner
within
week
addit
virolog
character
could
perform
period
approxim
week
initi
report
human
infect
numer
laboratori
identifi
virus
respons
mutat
bind
affin
host
cell
receptor
replic
without
prior
adapt
mous
ferret
model
limit
respiratori
droplet
transmiss
ferret
reduc
suscept
antivir
drug
substanti
infer
obtain
molecularli
base
surveil
use
knowledg
gain
gof
studi
irat
use
data
accumul
assess
reassess
risk
pose
virus
compar
zoonot
influenza
virus
determin
risk
greater
subtyp
virus
recent
gof
studi
focus
specif
virus
identifi
mutat
ie
associ
enhanc
mammalian
replic
research
also
assess
antigen
relationship
novel
virus
exist
prepandem
vaccin
candid
collect
virolog
find
along
molecular
marker
identifi
led
collabor
center
influenza
vaccin
manufactur
rapidli
develop
candid
vaccin
virus
led
depart
health
human
servic
perform
human
clinic
trial
stockpil
vaccin
unit
state
pandem
prepared
shave
month
time
requir
deploy
vaccin
need
coordin
intern
surveil
activ
global
share
virus
improv
especi
wake
pandem
emerg
virus
china
molecularli
base
surveil
great
potenti
rapid
risk
assess
sampl
collect
part
activ
passiv
surveil
system
realtim
feedback
investig
field
author
make
polici
decis
relat
poultri
outbreak
contain
clinic
intervent
diagnost
methodolog
cite
exampl
remain
critic
futur
addit
build
laboratori
capac
priorit
countri
impact
endem
viru
circul
higher
incid
human
infect
abil
screen
virus
amino
acid
marker
lineageassoci
molecular
determin
sequenc
pyrosequenc
mass
spectrometri
realtim
revers
transcript
rt
pcr
assay
becom
realiti
laboratori
recent
year
rang
speed
molecular
surveil
avian
influenza
virus
continu
improv
notwithstand
gof
studi
need
inform
interpret
genet
data
obtain
natur
occur
virus
despit
recent
gain
understand
molecular
basi
phenotyp
properti
hpai
lpai
virus
data
requir
fulli
elucid
mechan
influenza
virus
pandem
potenti
caus
sever
diseas
evolv
replic
mammalian
host
especi
true
studi
offer
insight
virolog
molecular
chang
associ
increas
capac
mammalian
transmiss
hallmark
pandem
influenza
virus
outlin
gof
studi
provid
critic
inform
molecularli
base
surveil
well
research
group
sequenc
character
experiment
test
virus
besid
answer
fundament
question
molecular
basi
key
phenotyp
characterist
avian
influenza
virus
gof
data
use
launch
outbreak
investig
alloc
resourc
eg
cambodia
develop
criteria
influenza
risk
assess
tool
make
difficult
sometim
costli
pandem
plan
polici
decis
prepar
cvv
purchas
prepandem
vaccin
stockpil
eg
china
detect
gof
mutat
hpai
lpai
virus
prompt
immedi
public
health
respons
differ
action
would
occur
rise
case
number
alon
concurr
detect
gof
mutat
increas
human
case
could
signal
humantohuman
transmiss
begun
situat
rapid
respons
paramount
coupl
result
obtain
gof
studi
enhanc
surveil
prepared
commun
scientist
veterinari
public
health
expert
regul
polici
advis
opportun
use
advanc
methodolog
avail
address
continu
threat
pose
influenza
virus
pandem
potenti
